Disclaimer: We aren’t paid by companies to write analysis on Trading For Millions ― it’s 100% independent. We also aren’t licensed to provide financial advice on the blog. Trading For Millions analyses companies we own for fun ― and it’s mostly biased. You should consider your own financial position and perform research on any company detailed on Trading For Millions.
We just wanted to send you a short note.
In case you missed it, check out this six minute video on the Joe Rogan show:
Joe Rogan ― a former television host and mixed martial arts commentator, with one of the largest podcasts around the world ― explains how the World Anti-Doping Agency (WADA) changed the rules for medical cannabis oils.
They call it the “Nate Diaz rule”.
The rule change has paved the way for Impression Healthcare’s (ASX:IHL) phase one trial ― Synthetic CBD Oil for Improvement of Radiological Signs of Traumatic Brain Injury and Neurocognitive Function in Australian Rules and Rugby Players following Concussion ― starting soon. The trial is about concussion and long-term traumatic brain injuries causing sportspeople to have lifelong brain injuries, and offers significant untapped share price potential which the market ignores.
We highly recommend checking out the video ― its groundbreaking. It will help you understand the true magnitude of this phase one trial (one of four) and what it could do for the company’s share price. Plus, if you haven’t already, check out our full in-depth analysis on the remaining upcoming trials and our latest view on Impression Healthcare here.